Physicians and healthcare professionals attended a virtual conference Oct. 2, 2020, on Personalized IBD and VEO-IBD: Genomics, Microbiome, Biologics and Beyond. The one-day course was designed to present the latest developments in research and clinical care for very early onset inflammatory bowel disease (VEO-IBD) and pediatric IBD.
Participants received a comprehensive overview of the genomic, immunologic and microbiome discoveries in VEO-IBD and in pediatric IBD, and of advances in the diagnosis, medical and surgical management of the disease. The conference included lectures by nationally and internationally recognized experts, interactive panel discussions and case presentations from the audience.
- Immune Dysregulation in VEO-IBD by Kathleen E. Sullivan, MD, PhD
- Genetic Discoveries: Lessons We Learned by Judith R. Kelsen, MD
- When to Go to the OR? A panel discussion with moderator Andrew B. Grossman, MD
- Predicting Outcomes and Personalizing Treatment Decisions for Patients with Crohn's Disease by Corey Seigel, MD, MS
This year's course directors included Robert Baldassano, MD, and Andrew Grossman, MD, Co-directors of the Center for Pediatric Inflammatory Bowel Disease, and Judith Kelsen, MD, Director of the Very Early Onset IBD Program.